Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (278)
- COVID-19 (163)
- Safety monitoring and information (101)
- Legislation (95)
- Compliance and enforcement (70)
- Manufacturing (55)
- Vaping hub (55)
- Labelling and packaging (37)
- Import and export (28)
- Scheduling (national classification system) (27)
- Medicinal cannabis hub (25)
- Sunscreens (16)
- Weight loss products (15)
- Shortages and supply disruptions (14)
- Committees and advisory bodies (9)
- Cosmetics (5)
- Unique Device Identification (UDI) hub (4)
- Clinical trials (3)
- Fees and payments (2)
- Prescription opioids hub (2)
- Urogynaecological (transvaginal) surgical mesh hub (2)
- Breast implant hub (1)
Search
33 result(s) found, displaying 26 to 33
-
Regulatory decision noticesMore applications for Good Manufacturing Practice (GMP) clearances can now be assessed under the TGA’s MRA pathway.
-
Media releasesFollowing a safety investigation into pholcodine the TGA are cancelling 55 products (from the ARTG) and recalling them from pharmacy shelves due to an increased risk of anaphylactic reactions.
-
BlogMake small changes to how you think about paracetamol.
-
News articlesThe Pharmacovigilance Inspection Program (PVIP) Risk Assessment Survey is now open until 18 December 2022 for medicine sponsors to complete.
-
BlogHow to find information about the inactive ingredients in your medicines.
-
News articlesAustralian launch of a new product called Nyxoid nasal spray for opioid overdoses
-
BlogFor some people, vitamins are an important part of their health. Learn how the TGA regulates vitamins.
-
Regulatory decision noticesMake a request under section 9D of the Therapeutic Goods Act 1989.